BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9252686)

  • 1. Retinoblastoma (pRb) protein immunoexpression in colorectal cancer.
    Chetty R; Subramoney T; Singh J; Harilal P
    Anticancer Res; 1997; 17(4A):2593-7. PubMed ID: 9252686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of key cell-cycle checkpoint proteins in colorectal tumours.
    McKay JA; Douglas JJ; Ross VG; Curran S; Loane JF; Ahmed FY; Cassidy J; McLeod HL; Murray GI
    J Pathol; 2002 Apr; 196(4):386-93. PubMed ID: 11920733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM; Hoffman HT; Robinson RA
    J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
    Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
    Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression.
    Milicevic Z; Bogojevic D; Mihailovic M; Petrovic M; Krivokapic Z
    Int J Oncol; 2008 Jun; 32(6):1169-78. PubMed ID: 18497978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p16 and lack of pRB in primary small cell lung cancer.
    Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
    J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of retinoblastoma protein and p16INK4 protein expression in extrahepatic bile duct carcinomas.
    Cui X; Hui AM; Li X; Shi YZ; Takayama T; Hatakeyama K; Makuuchi M
    Hepatogastroenterology; 2000; 47(35):1216-20. PubMed ID: 11100316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma and p53 protein expression in sporadic colorectal cancers.
    Chetty R; Subramoney T; Singh JP
    Eur J Surg Oncol; 1998 Oct; 24(5):436-9. PubMed ID: 9800976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
    Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
    Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis.
    Yamamoto H; Soh JW; Monden T; Klein MG; Zhang LM; Shirin H; Arber N; Tomita N; Schieren I; Stein CA; Weinstein IB
    Clin Cancer Res; 1999 Jul; 5(7):1805-15. PubMed ID: 10430085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.